ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:

Mark L. Fuerst

Mark L. Fuerst

Mark L. Fuerst is a freelance health and medical writer for ConsultantLive, Rheumatology Network, Psychiatric Times, and other UBM publications. He writes about rheumatology, psychiatry, neurology, endocrinology, oncology, and men’s health.

Posts by Author

Are you up-to-date on the latest findings in mild cognitive impairment, dementia, and depression in elderly patients?

In a new study, an intensive lifestyle intervention did not markedly decrease A1c but had significant impact on need for medication.

Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.

Too many—or too few—pounds—could be a factor in migraine pathogenesis. Details here.

Study authors propose a new asthma patient “phenotype” in which a previous severe event is the sole predictor of another one.

Results of a recent study into the role of lipids in atopic asthma could help identify new targets for therapy.

New research suggests it’s possible to reverse the metabolic impact of childhood obesity and avert T2DM in adulthood.

Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.

Find research on diabetes patients that could shift your thinking on home blood glucose monitoring; metformin efficacy in T1DM; and race and A1c.

New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.